Tag: Oncology

Hairy Frosted Glass Slides Capture Circulating Tumor Cells for Screening and Early Diagnosis

Biopsies are typically the way prostate cancer is identified, but prostate cancers also release circulating tumor cells (CTCs) that are telltale signs of the presence of the disease. Because they’re so rare and difficult to separate from whole blood, CTCs remain rarely used for establishing diagnoses. Researchers from the Chinese Academy of S (Read more...)

Advanced Cancer Diagnostics Reduce Frequency of Misdiagnoses: Interview with Precipio CEO Ilan Danieli

According to 2010-2012 data from the National Cancer Institute (NCI), 40% of men and women will be diagnosed with cancer in their lifetime. In all its forms, cancer is known to be a clinically and emotionally challenging disease to manage. Despite the fact that each year 455 men and women per 100,000 patients are diagnosed […]

Another Approval for Personalized Cellular CAR T Therapy

The FDA has given another approval to Novartis for chimeric antigen receptor (CAR) T-cell therapy KYMRIAH, a personalized cell therapy product, the development of which was originated at University of Pennsylvania. Originally approved for children and young adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, it is (Read more...)

Noninvasive Brain Tumor Biopsy Using Focused Ultrasound

Unlike many other tumors, ones found in the brain are usually too dangerous to take biopsies of. Now the researchers at Washington University School of Medicine in St. Louis came up with a revolutionary new way of using focused ultrasound to get tumors to release biomarkers that can then be spotted using blood samples. Thanks to […]

Genetically Engineered Tattoo Shows Up if Person Has Cancer

As everyone knows, early diagnosis brings the best chance of fighting cancer. At ETH Zurich, a Swiss technical university, researchers genetically modified skin cells to produce a tattoo that makes itself visible only when the person wearing it has signs of cancer. The technology consists of a “synthetic gene network” that activates the (Read more...)

IBM Watson Artificial Intelligence System for Cancer Care: Interview with Elekta’s Andrew Wilson

Elekta, the big name in radiotherapy, radiosurgery, and oncology informatics that’s based in Sweden, recently partnered with IBM to offer the Watson for Oncology artificial intelligence (AI) platform along with its MOSAIQ Oncology Information System and other cancer care solutions. According to Richard Hausmann, the CEO of Elekta, it is &ldqu (Read more...)

New Highly Effective Camera for Spotting Dye Tagged Tumors

A collaboration between researchers at University of Illinois at Urbana-Champaign and Washington University in St. Louis has led to the development of a highly sensitive new camera for detecting fluorescent markers tagged on cancer tumors. It is smaller, more accurate, and relies on cheaper parts than existing devices used to detect the same near-i (Read more...)

ivWatch Detects IV Infiltrations and Extravasations: Interview with Gary Warren, President and CEO

ivWatch is a medical device manufacturer who we met with during CES 2018 in Las Vegas a couple months ago. They have developed of a non-invasive device that aims to establish a new standard of care for peripheral intravenous (IV) monitoring. The FDA-cleared ivWatch  continuously monitors a patient’s IV for the early detection of inf (Read more...)

Partial Wave Spectroscopy Spots Cells Turning to Cancer

Detecting cancer in the body usually happens when the disease is already well underway to being mortally dangerous. Although there’s a myriad of cancers and ways to detect them, diagnostic tests typically look for biomarkers produced by tumors. And the bigger the tumor, the more biomarkers it releases, so the bigger it is the easier [… (Read more...)